A case study in pharma chilling and freezing

Copywrite Ceva-Phylaxia 2

This week’s free feature on 23/09/19For French animal vaccine producer Ceva-Phylaxia, cryogenics technology plays a significant role in its day-to-day business. The company produces live, as well as inactivated, viral and bacterial vaccines across its 13 R&D centres and 23 production sites in 44 countries around the globe, which need ...

You must be a subscriber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content today!

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $310.